pediatric-chronic
Living With Chronic Eczema: Long-Term Management for Children
Chronic eczema requires daily moisturizing, trigger avoidance, and consistent treatment — not just flare rescue. First-ever AAD pediatric atopic dermatitis guidelines (2026) support topical corticosteroids as affordable first-line therapy.
Talk to a clinician
Lena Park, PNP — Pediatric NP
kids & families. Gale can match you with a licensed clinician for a visit.
Find care →Why Eczema Is Considered Chronic
Atopic dermatitis is driven by a combination of a skin barrier defect and immune system overreactivity 1Ref 1American Academy of Dermatology (2026).Guidelines of care for the management of atopic dermatitis in pediatric patients.Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle. Even when the skin looks clear, the barrier is not fully normal — which is why dryness, itching, and flares return predictably without ongoing care. Thinking of eczema as a chronic condition to manage daily, rather than a problem to solve only during flares, leads to better outcomes and fewer severe episodes. It often co-occurs with asthma and allergic rhinitis (hay fever) — a pattern called the 'atopic triad' 1Ref 1American Academy of Dermatology (2026).Guidelines of care for the management of atopic dermatitis in pediatric patients.Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle.
The Daily Skin Care Routine: Moisturize First
Daily moisturizing is the single most important non-prescription intervention 1Ref 1American Academy of Dermatology (2026).Guidelines of care for the management of atopic dermatitis in pediatric patients.Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. Thick creams or ointments (fragrance-free) applied immediately after bathing — within a few minutes, before the skin fully dries — help seal in moisture and reinforce the skin barrier. Bathing in lukewarm (not hot) water for a short time, using gentle fragrance-free cleanser only where needed, then patting (not rubbing) dry before moisturizing is the standard routine 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. Quantity matters — enough moisturizer to feel slightly greasy on application. This routine applies every day, not only during flares.
Using Prescription Treatments Correctly
Topical corticosteroids are the first-line treatment for eczema flares, recommended in the 2026 AAD pediatric atopic dermatitis guidelines for their effectiveness, affordability, and accessibility 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. A common reason they 'stop working' is inconsistent use or using too little. The child's provider prescribes a specific strength for specific body areas (stronger steroids are generally not used on the face or skin folds). Some providers recommend 'proactive' treatment — applying a low-strength topical corticosteroid to areas that flare predictably, once or twice a week, even when the skin looks calm, to prevent flares from taking hold 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. Topical calcineurin inhibitors (non-steroid prescription creams) are another option for sensitive areas. For moderate-to-severe eczema that does not respond to standard therapy, newer biologics (such as dupilumab) are now approved for children 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention.
Identifying and Managing Triggers
Common eczema triggers include: dry air (especially in winter, forced air heat); sweating from exercise or heat; rough or wool fabrics; fragranced soaps, lotions, or laundry detergents; pet dander in sensitive children; and food (most commonly cow's milk, egg, peanut, wheat, or soy in young children with severe eczema — though food allergy as a trigger is less common than parents often assume and should be evaluated rather than assumed) 1Ref 1American Academy of Dermatology (2026).Guidelines of care for the management of atopic dermatitis in pediatric patients.Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle. Notably, the 2026 AAD guidelines found insufficient evidence to support dietary elimination or probiotic use for eczema prevention in most children 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. Stress can also trigger flares in older children. Identifying triggers is often a matter of keeping a simple log of flare timing and what changed.
Managing the Itch-Scratch Cycle and Sleep
Itch is often the most disruptive part of chronic eczema, particularly at night. Scratching worsens the skin barrier and triggers more inflammation — the itch-scratch cycle 1Ref 1American Academy of Dermatology (2026).Guidelines of care for the management of atopic dermatitis in pediatric patients.Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle. Strategies to interrupt it include keeping nails short and smooth, dressing children in soft, breathable cotton at night, keeping the sleep environment cool, and using prescribed treatments proactively before bedtime. For children with significant nighttime itch affecting sleep, the care team may discuss additional options. Poor sleep affects every aspect of a child's functioning and well-being; it is worth discussing directly with the dermatologist or pediatrician if it is a persistent problem.
When to Escalate Care
A referral to a pediatric dermatologist or allergist is worth considering when: the eczema is not adequately controlled with standard treatment, flares are frequent and severe, the condition significantly affects sleep or quality of life, a food allergy trigger is suspected and needs formal evaluation, or the diagnosis is uncertain 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention. The 2026 AAD pediatric guidelines — the first such dedicated guidelines ever issued — provide an evidence-based framework for these decisions, including criteria for advancing to systemic therapies and biologics 2Ref 2American Academy of Dermatology (2026).AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations).Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention.
Common questions
Will my child outgrow eczema?
Many children do improve significantly with age, and some outgrow it entirely. The likelihood varies by severity and the presence of other atopic conditions like asthma. Mild eczema that starts in infancy often resolves by school age. Severe eczema persisting into middle childhood is more likely to continue.
Is it safe to use steroid cream on my child long-term?
Topical corticosteroids are safe when used as directed — the right strength, on the right body areas, for the right duration. The risk of side effects (skin thinning) is associated with overuse of high-potency steroids, especially in skin folds or on the face. Use the lowest effective strength as prescribed and discuss any concerns with the child's provider.
Should I eliminate foods to help my child's eczema?
Food elimination should not be done without guidance from a doctor or allergist. In young children with severe eczema, IgE-mediated food allergy may be a contributing factor and is worth formal allergy evaluation — but many families eliminate foods unnecessarily, risking nutritional gaps. Most children with eczema do not have a food trigger, and the 2026 AAD guidelines found insufficient evidence to recommend dietary interventions for eczema prevention.
What is 'wet wrap therapy'?
Wet wrap therapy involves applying a topical treatment and then wrapping the skin in damp and then dry layers of fabric — often used for severe or widespread flares. It is typically taught by a dermatologist or nurse and used short-term to help very severe eczema. It is not a first-line daily approach.
Talk to a clinician
Lena Park, PNP — Pediatric NP
kids & families. Gale can match you with a licensed clinician for a visit.
Find care →When to get care right away
- —Eczema-affected skin becomes very red, warm, crusty with yellow or honey-colored weeping — possible skin infection (impetigo or cellulitis)
- —Child develops fever alongside a worsening eczema flare
- —Widespread, painful blistering rash — possible eczema herpeticum (a viral infection requiring urgent treatment)
- —Rapid spread of swollen, red skin with fever and the child looks unwell
Seek urgent or emergency care for signs of spreading skin infection with fever, or any blistering widespread rash in a child with eczema — eczema herpeticum is a serious infection that requires prompt treatment.
This article is general health information for parents, not a treatment prescription. Work with your child's pediatrician or dermatologist for a management plan suited to your child.
References
- 1.American Academy of Dermatology (2026). Guidelines of care for the management of atopic dermatitis in pediatric patients. Journal of the American Academy of Dermatology. doi:10.1016/j.jaad.2026.02.011 ✓Skin barrier defect and immune dysregulation as the mechanism of atopic dermatitis; atopic triad; daily moisturizing as foundational non-prescription management; itch-scratch cycle
- 2.American Academy of Dermatology (2026). AAD Issues First-Ever Pediatric Atopic Dermatitis Guidelines (27 evidence-based recommendations). Journal of the American Academy of Dermatology / aad.org newsroom. link ✓Topical corticosteroids as first-line therapy; proactive use on previously affected areas; dupilumab and biologics for moderate-to-severe disease; insufficient evidence for dietary elimination or probiotics in prevention
2 sources, numbered by first appearance. General health information, not medical advice — synthetic demonstration content.